The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.
Expanded CD14+CD16+Monocyte Subpopulation in Patients with Acute and Chronic Infections Undergoing Hemodialysis
Open accessAbstract
Infections are frequent complications in end-stage renal failure patients undergoing hemodialysis (HD), and peripheral blood monocytes are important cells in host defense against infections. The majority of circulating monocytes express high levels of lipopolysaccharide receptor antigen CD14 and are negative for the immunoglobulin Fcγ receptor type III (CD16). We studied the occurrence of a minor subpopulation coexpressing low levels of CD14 together with CD16 in HD patients. In healthy controls CD14+CD16+monocytes account for 8% ± 4% of CD14+monocytes, with an absolute number of 29 ± 14 cells/μl. In stable HD patients the CD14+CD16+subpopulation was significantly elevated (14% ± 3%, or 66 ± 28 cells/μl), while the number of CD14++monocytes (monocytes strongly positive for CD14) remained constant. In HD patients suffering from chronic infections a further rise in CD14+CD16+monocytes was observed (128 ± 71 cells/μl;P< 0.01) such that this subpopulation constituted 24% of all blood monocytes. In contrast, numbers of CD14++cells did not change compared to those for stable HD patients, indicating that the CD14+CD16+monocyte subpopulation was selectively expanded. During acute infections the CD14+CD16+cell subpopulation always expanded. A whole-blood assay revealed that CD14+CD16+monocytes exhibited a higher phagocytosis rate for Escherichia coli bacteria than CD14++monocytes, underlining their role during host defense. In addition, CD14+CD16+monocytes expressed higher levels of major histocompatibility complex (MHC) class II antigens (HLA-DR, -DP, and -DQ) and equal amounts of MHC class I antigens (HLA-ABC). Thus, CD14+CD16+cells constitute a potent phagocytosing and antigen-presenting monocyte subpopulation, which is expanded during acute and chronic infections commonly observed in chronic HD patients.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
de Waal Malefyt, R., Abrams, J., Bennett, B., Figdor, C. G., & de Vries, J. E. (1991) · The Journal of experimental medicine · doi:10.1084/jem.174.5.1209 · Cited by 3,762
Cited by
The CD14+ CD16+ blood monocytes: their role in infection and inflammation
Ziegler-Heitbrock, L. (2007) · Journal of Leukocyte Biology · doi:10.1189/jlb.0806510 · Cited by 1,041
Human Monocyte Subsets and Phenotypes in Major Chronic Inflammatory Diseases
Kapellos, T. S., Bonaguro, L., Gemünd, I., Reusch, N., Saglam, A., Hinkley, E. R., & Schultze, J. L. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.02035 · Cited by 890
The Proinflammatory CD14+CD16+DR++ Monocytes Are a Major Source of TNF
Belge, K.-U., Dayyani, F., Horelt, A., Siedlar, M., Frankenberger, M., Frankenberger, B., Espevik, T., & Ziegler-Heitbrock, L. (2002) · The Journal of Immunology · doi:10.4049/jimmunol.168.7.3536 · Cited by 883
Hearps, A. C., Martin, G. E., Angelovich, T. A., Cheng, W., Maisa, A., Landay, A. L., Jaworowski, A., & Crowe, S. M. (2012) · Aging Cell · doi:10.1111/j.1474-9726.2012.00851.x · Cited by 547
Immune cell dysfunction and inflammation in end-stage renal disease
Betjes, M. G. H. (2013) · Nature Reviews Nephrology · doi:10.1038/nrneph.2013.44 · Cited by 542
Metadata
- Authors
- Nockher, W. A., & Scherberich, J. E.
- Venue
- Infection and Immunity
- Publisher
- American Society for Microbiology
- Published
- 1998-06
- Volume
- 66
- Issue
- 6
- Pages
- 2782-2790
- ISSN
- 0019-9567 (ISSN-L)
- 1098-5522
- OpenAlex
- W2112117215
- Cited by
- 188
- References
- 1
- FWCI
- 3.03
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Expanded CD14+CD16+Monocyte Subpopulation in Patients with Acute and Chronic Infections Undergoing Hemodialysis. https://app.cochat.ai/papers/10.1128/iai.66.6.2782-2790.1998
- The paper
- Nockher, W. A., & Scherberich, J. E. (1998). Expanded CD14+CD16+Monocyte Subpopulation in Patients with Acute and Chronic Infections Undergoing Hemodialysis. Infection and Immunity. https://doi.org/10.1128/iai.66.6.2782-2790.1998
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.